Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Saint-Cloud, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Aspirin and Folic Acid Treatment for Patients with Sudden Sensorineural Hearing Loss
FranceStudy of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery
FranceStudy of durvalumab and tremelimumab with or without hepatic arterial infusion of gemcitabine and oxaliplatin in patients with high tumor burden hepatocellular carcinoma
FranceSafety and efficacy study of nadofaragene firadenovec administered to the renal pelvis in adults with low-grade upper tract urothelial carcinoma
FranceComparison of compression therapy alone versus compression therapy with phenoxymethylpenicillin for preventing recurrent erysipelas in lower limbs
FranceStudy comparing low-dose versus standard-dose epinephrine for better brain recovery in patients with out-of-hospital cardiac arrest
FranceStudy of disitamab vedotin alone or with pembrolizumab in patients with locally advanced or metastatic urothelial cancer that expresses HER2
FranceStudy of tucatinib and trastuzumab for patients with HER3-mutant and HER2-not amplified metastatic breast cancer
FranceStudy of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment
FranceFranceStudy of brentuximab vedotin for maintenance therapy in patients with cutaneous T-cell lymphoma after stem cell transplant
FranceStudy comparing 3-week versus 6-week antibiotic treatment for patients with drained pyogenic liver abscess
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma and multiple myeloma treatments, including studies of novel therapies like duvelisib for T-cell lymphoma and odronextamab for follicular lymphoma.
Several studies are evaluating combination therapies and comparing new treatment approaches against standard care.
Comprehensive research into various types of breast cancer, with particular focus on hormone receptor-positive and triple-negative variants. Studies include early detection methods and novel therapeutic combinations.
Trials incorporate innovative approaches like ctDNA monitoring and targeted therapies.
Research focusing on targeted therapies for various advanced cancers, including studies of biliary tract cancer and non-small cell lung cancer treatments.
Emphasis on immunotherapy combinations and precision medicine approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
